142 results on '"DAPTOMYCIN"'
Search Results
2. Dual release of daptomycin and BMP-2 from a composite of β-TCP ceramic and ADA gelatin
3. In vitro effects of anti-MRSA agent adsorption onto the AN69ST hemofilter
4. Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement
5. A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category
6. Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation
7. Usefulness of daptomycin lock therapy in children with catheter-related bacteremia after failed vancomycin lock therapy
8. Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri
9. The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study
10. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system
11. A novel strategy of gene screen based on multi-omics in Streptomyces roseosporus
12. Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
13. The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report
14. PK/PD modeling of daptomycin against MRSA and MRSE and Monte Carlo simulation for bacteremia treatment
15. Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease
16. Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection
17. In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis
18. A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli
19. Highly Sensitive Fluorescence Detection of Daptomycin in Murine Samples through Derivatization with 2,3-Naphthalenedialdehyde
20. Model lipid systems and their use to evaluate the phase state of biomembranes, their mechanical properties and the effect of non-conventional antibiotics: the case of daptomycin
21. Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline
22. Selection of Resistance to Daptomycin in Methicillin-Resistant Staphylococcus aureus: Role of Homo- and Hetero-Mutations
23. Time-kill curves of daptomycin and Monte Carlo simulation for the treatment of bacteraemia caused by Enterococcus faecium
24. Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
25. Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis
26. Pleiotropic regulation of daptomycin synthesis by DptR1, a LuxR family transcriptional regulator
27. Updates on Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia
28. Pleiotropic regulation of daptomycin synthesis by DptR1, a LuxR family transcriptional regulator
29. Metabolic changes associated with adaptive resistance to daptomycin in Streptococcus mitis-oralis
30. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis
31. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration
32. Synthetic biology, genome mining, and combinatorial biosynthesis of NRPS-derived antibiotics: a perspective
33. In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design
34. Encapsulation in Polymeric Microparticles Improves Daptomycin Activity Against Mature Staphylococci Biofilms—a Thermal and Imaging Study
35. Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics
36. Regulatory and biosynthetic effects of the bkd gene clusters on the production of daptomycin and its analogs A21978C1–3
37. Linezolid versus daptomycin treatment for periprosthetic joint infections: a retrospective cohort study
38. Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections
39. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis
40. A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains
41. Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin
42. Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?
43. Surviving Sepsis in the Intensive Care Unit: The Challenge of Antimicrobial Resistance and the Trauma Patient
44. Optimization of the Biosynthesis Conditions of Daptomycin by the Biostatistical Methodology
45. Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections
46. Improved production of Daptomycin in an airlift bioreactor by morphologically modified and immobilized cells of Streptomyces roseosporus
47. Comprehensive antibiotic-linked mutation assessment by resistance mutation sequencing (RM-seq)
48. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study
49. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial
50. Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.